INSDOTCHealthcare · Drug Manufacturers - Specialty & Generic

Instadose Pharma Corp.

$0.00+0.00%(+$0.00)

TickerSpark Score

41/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INSD research report →

52-Week Range0% of range

Low $0.00

Current $0.00

High $0.00

Companywww.instadosepharma.com

Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.

CEO: Antonio Rocco Franchino
IPO: 2020
Employees: 2
HQ: Chesapeake, VA, US

Price Chart

-90.91% · this period

Valuation

Market Cap: $53.19K
P/E: -0.01
P/S: 0.00
P/B: -0.06
EV/EBITDA: -0.53
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: 503.52%
ROIC: 372.55%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-589,000 · -1668.08%
EPS: $-0.00 · -1500.00%
Op Income: $-462,023
FCF YoY: 0.00%

Performance & Tape

52W High: $0.00
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: -401.63
Avg Volume: 466.996

Get TickerSpark's AI analysis on INSD

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime